Society of Nuclear Medicine, Journal of Nuclear Medicine, 7(52), p. 1073-1078, 2011
DOI: 10.2967/jnumed.110.085142
Full text: Download
Glucagon-like peptide-1 (GLP-1) receptor imaging is superior to somatostatin receptor subtype 2 (sst(2)) imaging in localizing benign insulinomas. Here, the role of GLP-1 and sst(2) receptor imaging in the management of malignant insulinoma patients was investigated.